63rd Western Intermountain Neurological Organization (WINO) Conference
63rd WINO Conference
Save the Date
Friday, March 21, 2025
University Marriott Park Hotel
480 Wakara Way, Salt Lake City, UT 84108
KEYNOTE SPEAKERS
Joseph E. Safdieh, MD FAAN
Gertrude Feil Associate Dean of Curricular Affairs
Vice Chair of Education and Professor of Neurology
Weill Cornell Medical College
Joseph E. Safdieh, MD is the Gertrude Feil Associate Dean of Curricular Affairs, Vice Chairman for Education and Professor of Neurology at Weill Cornell Medicine. He received his bachelors degree in neuroscience, summa cum laude, from the College of Arts and Science of New York University. He received his medical degree (MD) from the New York University School of Medicine, where he received the Alpha Omega Alpha Award for graduating first in his class. He completed his neurology residency training at the Weill Cornell Campus of New York Presbyterian Hospital, where he also served as Chief Resident in the Department of Neurology. Dr. Safdieh is a member of Phi Beta Kappa and Alpha Omega Alpha, the medical honors society.
Dr. Safdieh was the director of the medical student Neurology Clerkship for the Weill Cornell Medical College, the medical director of the Neurology Clinic at New York-Presbyterian Hospital and also served as Director of Outpatient Training for the Neurology Residency Program As associate dean for curricular affairs, he is responsible for overseeing the implementation and quality of the MD curriculum at Weill Cornell Medicine. He is well respected as an innovative medical educator, and has developed numerous curricula for the teaching of neurology to medical students and other physicians. He has been recognized for his excellence in medical student education locally, nationally and internationally.
Dr. Safdieh has served in various committee roles with the American Academy of Neurology, where he is currently vice chair of the publications committee. He served as chair of the Consortium of Neurology Clerkship Directors. He is currently editor-in-chief of Neurology Today, the official news source of the American Academy of Neurology.
Anastasia Zekeridou, MD, PhD, FAAN
Senior Associate Consultant
Associate Professor of Neurology and Laboratory Medicine and Pathology
Neuroimmunology Laboratory Co-Director
Mayo Clinic College of Medicine
Dr. Zekeridou is an Associate Professor of Neurology and Laboratory Medicine and Pathology and Co-Director of the Neuroimmunology Laboratory at Mayo Clinic in Rochester, Minnesota. Dr. Zekeridou earned her MD and PhD degrees in Greece and completed her neurology training in the University Hospital of Lausanne in Switzerland (CHUV) before joining Mayo Clinic, initially as a research fellow in the Neuroimmunology Laboratory, then autoimmune neurology clinical fellow. She has been on staff at Mayo Clinic Rochester since 2018, seeing patients in the Autoimmune Neurology Clinic and working in the Neuroimmunology Laboratory.
Dr. Zekeridou’s research interests are on neurological autoimmunity including paraneoplastic neurological diseases and complications of cancer immunotherapy, autoimmune movement disorders including stiff person spectrum disorders, neural autoantibody discovery and utility of biomarkers to aid diagnosis, prognosis and therapeutic decision-making for patients with neurological autoimmunity.
Deborah Hall, MD PhD
Department of Neurological Sciences
Rush University
Deborah Hall MD PhD is a professor, an adult neurologist and movement disorder specialist at Rush University Medical Center in Chicago. She is Director of the Fragile X-associated Tremor Ataxia Syndrome (FXTAS) Clinic at Rush, founder of the Chicago Fragile X Research Group and Co-Director of the Huntington’s Disease Center of Excellence at Rush. She holds the Parkinson’s Foundation Endowed Chair, is the Chief of the Movement Disorder Division at Rush University, and is Chair of the Rush University Institutional Review Board. She has expertise in large epidemiology studies, clinical trials, and human subject’s research. She has been conducting research in FXTAS for over 20 years, including several phenotype and epidemiological papers related to FXTAS. She has participated in 17 NIH R01 projects, many related to FXTAS. She is NIH R01 funded, serves on permanent NIH study section and has participated in 17 NIH R01 projects, many related to ataxias. She has a clinical practice of movement disorder patients, with additional research focuses in Huntington Disease, multiple system atrophy, and clinical trials in Parkinson disease.